Connect with us

Health

WHO Partners Health Authorities to Bolster Monkeypox Testing in Africa

Published

on

Monkeypox

By Adedapo Adesanya

The World Health Organisation (WHO) has announced that it was working with national health authorities in Africa to bolster surveillance and laboratory diagnosis to detect cases and deter a silent spread of the virus.

The continent as of June 28 has reported 1,821 cases in 13 countries of which 109 are laboratory confirmed in nine countries. The number of confirmed cases accounts for 2 per cent of the more than 4,500 confirmed cases globally.

However, there are a large number of suspected cases in the region, 81 per cent of which are in the Democratic Republic of the Congo, underlining the need for increased diagnostic capacity.

While all African countries have the polymerase chain reaction machines needed to test for monkeypox thanks to reinforced laboratory capacity in the wake of COVID-19, many lack reagents and in some cases training in specimen collection, handling and testing.

As a result, WHO is working to secure 60,000 tests for Africa, with around 2,000 tests and reagents to be shipped to high-risk countries and 1,000 to those facing lower risk.

Over the past months, five more African countries have received donations of reagents from partners, bringing to 12 the number of countries in the region with enhanced monkeypox diagnostic capacity. Another group of countries in West Africa will receive reagents after participating in a training.

Outside the six countries in Africa with a history of human transmission, monkeypox has also been reported in three countries which have not previously had any human cases. These include Ghana, Morocco and South Africa, which have confirmed the disease in two patients with no travel history, suggesting there is a high possibility of local transmission.

“The geographic spread of monkeypox to parts of Africa where cases have never been detected before is a worrying sign,” said Dr Matshidiso Moeti, WHO Regional Director for Africa. “It is critical that we support national efforts to boost surveillance and laboratory diagnosis, which are the cornerstones of disease control.”

To deepen the analysis of monkeypox transmission patterns, WHO is supporting countries to capitalize on the improved genomic sequencing capacity built during the COVID-19 pandemic.

Many years of research have led to the development of new and safer (second- and third-generation) vaccines for smallpox, some of which may be useful for monkeypox and one of which (MVA-BN) has been approved for the prevention of monkeypox. However, supplies are limited.

“What happened in the early days of the COVID-19 vaccine rollout when Africa watched on the sidelines as other countries snapped up limited supplies must not be allowed to recur. There are some signs that this is already happening,” said Dr Moeti. “The current global spotlight on monkeypox should be a catalyst to beat this disease once and for all in Africa. For this, we know vaccines are a critical tool.”

WHO is also working closely with the Member States and partners to define what type of coordination mechanism could be put in place to ensure fair access to vaccines. There are many regulatory, legal, operational, technical, and other issues to clarify before an allocation mechanism is fully operational.

With limited vaccines and antivirals, WHO does not recommend mass vaccination for monkeypox but rather targeted vaccination for people who have been exposed or are at high risk including health workers, laboratory personnel and outbreak team responders.

Adedapo Adesanya is a journalist, polymath, and connoisseur of everything art. When he is not writing, he has his nose buried in one of the many books or articles he has bookmarked or simply listening to good music with a bottle of beer or wine. He supports the greatest club in the world, Manchester United F.C.

Click to comment

Leave a Reply

Health

DoorSpace Exits Meta Platforms Over Fact-checking System

Published

on

DoorSpace

By Aduragbemi Omiyale

A healthcare technology platform, DoorSpace, has announced its exit from all Meta platforms, citing value differences and company culture as reasons for the action.

Ahead of the inauguration of Mr Donald Trump as the President of the United States of America (USA) for a second term on tomorrow, Monday, January 20, 2025, Mr Mark Zuckerberg announced changes to his platforms’ fact-checking system.

“The only way that we can push back on this global trend is with the support of the US government, and that’s why it’s been so difficult over the past four years, when even the US government has pushed for censorship,” Mr Zuckerberg said in a video.

He said Meta was welcoming political discourse back on Facebook, Instagram and Threads with the new Community Notes system, which will enable users to write and rate notes that can be added onto posts.

Mr Zuckerberg explained that Meta would be working closely with Mr Trump’s upcoming administration by showing users more content that is politically charged and not checked by third-party fact checkers.

This decision of Meta did not go down well with DoorSpace, which said it has ceased any activity and would no longer spend marketing dollars to advertise on Meta platforms.

“Zuckerberg’s business decisions to rollback its fact checking system and to open up the platform to allow for misinformation, hate and bullying, especially against vulnerable minority groups, shows his lack of understanding on the importance of diversity and common decency.

“Incel culture will continue to grow and fester in that curated environment, leading to more violence against these groups in the real world,” the chief executive of DoorSpace, Ms Sarah M. Worthy, said.

“”I need to stand by my values and use my position as a healthcare tech leader to advocate for the individuals who are directly harmed in both their professional and personal lives by the hate and misinformation being spread on Zuckerberg’s platforms.

“The Meta that Zuckerberg has created has become a cesspool that sells its users’ data to the highest bidder while utilizing manipulative and dangerous tactics to keep people on the app as long as possible,” Ms Worthy added.

“Your data is not secure on their platforms, their algorithmic feed is designed to sow division and misinformation, and the company has announced that it does not view every American equally.

“There is no need for our business to spend money advertising there or any reason for our brand to maintain an active presence there anymore,” she said further.

Continue Reading

Health

Mums Feel Warmth Initiative Raises Postpartum Depression Awareness

Published

on

Mums Feel Warmth Postpartum Depression

By Modupe Gbadeyanka

A transformative webinar to raise awareness on postpartum depression (PPD) by nursing mothers has been organised by MSc Media and Communication students from the School of Media and Communications of the Pan-Atlantic University.

The programme titled Beyond Baby Blues: Understanding and Overcoming Postpartum Depression was held on January 7, 2025.

It was put together by the students under the Mums Feel Warmth initiative, with experts in the field invited to speak on the matter aimed at empowering mothers and fostering a sense of reassurance.

The webinar was to highlight the journey through postpartum depression, offering a message of hope, resilience, and the importance of mental health support for mothers everywhere.

One of the speakers, Dr Laja Odunuga, who is the Care Coordinator for AVON HMO, explained the difference between the common “baby blues” and the more severe, long-lasting PPD.

The discussion highlighted how PPD can manifest not just as sadness but through severe fatigue, disconnection from the newborn, and loss of interest in activities, which can last well beyond the typical two-week period associated with baby blues.

Another expert, Ms Otomfon Ibanga, the Assistant Lead Nurse for Q-Life Family Clinic, emphasised the role of support systems, urging families and friends to be vigilant for signs of PPD and to provide a nurturing environment.

She also discussed prevention strategies, including prenatal planning for support structures and post-delivery management through therapy or medication.

On his part, Dr Chimaraoke Obialo, who is the Medical Director of Life Amada Health Consultancy, addressed the stigma surrounding PPD, advocating for education to transform societal perceptions from judgement to support.

The webinar underscored the need for community involvement, not just in recognising symptoms but in actively participating in the healing process by offering emotional and practical support.

The Mums Feel Warmth webinar was more than just an educational session; it was a call to action for society to embrace and support new mothers dealing with PPD.

By fostering open conversations and providing platforms for sharing experiences, Mums Feel Warmth continues to lead the charge against the stigma of PPD.

The commitment shown by the panellists and attendees alike promises a future where every mother has access to the understanding and care needed to navigate through the complexities of postpartum depression, ensuring that the joy of motherhood is not overshadowed by mental health challenges.

Mums Feel Warmth, with its core values of empathy, compassion, hope, community, and education, speaks to the Sustainable Development Goal 3, advocating for good health and well-being.

The initiative is breaking the silence around PPD, a condition that can significantly impact new mothers in the critical period following childbirth.

Continue Reading

Health

NCDC Monitors HMPV Situation, Affirms Nigeria at Moderate Risk

Published

on

HMPV

By Adedapo Adesanya

The Nigeria Centre for Disease Control (NCDC) says the country is at “moderate” risk for Human Metapneumovirus (HMPV), a virus that leads to an upper respiratory tract infection with symptoms like cough, fever, and nasal congestion.

In a public health advisory, the Nigerian health agency said the federal government is closely monitoring the outbreak of the virus and is taking safety measures to “strengthen the country’s preparedness and response capacity”.

Recent reports indicate a significant rise in HMPV cases in China, as well as increased respiratory infections linked to HMPV in countries such as the United Kingdom (UK), France, and Germany, particularly during the winter season.

The NCDC said it conducted a risk assessment for the HMPV in collaboration with the Federal Ministry of Health and partners such as the World Health Organization (WHO), the US Centres for Disease Control and Prevention (USCDC), and the UK Health Security Agency (UKHSA).

“The assessment classified the risk of HMPV for Nigeria as moderate. This evaluation will inform and guide preparedness efforts, decision-making, and response strategies to mitigate potential impacts,” the advisory said.

It said the NCDC is working to give Nigerians “timely, accurate information and guidance to keep the Nigerian public informed and prepared”.

NCDC noted that it “in collaboration with Port Health Authorities, is taking proactive steps to ensure robust preparedness at all international points of entry (PoEs) in response to the dynamic risk assessment for Human Metapneumovirus (HMPV).

“These measures are designed to mitigate the potential risk of HMPV transmission through international travel.”

HMPV was first identified in the Netherlands in 2001 and the virus spreads through direct contact between people or when someone touches surfaces contaminated with it.

Children under two are most vulnerable to the virus alongside those with weakened immune systems such as the elderly and those with advanced cancer, according to medical experts.

There have also been worries that this could be like COVID-19, but experts have eased the fear as they are not similar because pandemics are typically caused by novel pathogens, which is not the case for HMPV.

Continue Reading

Trending